|
|
From Business model to Business model portfolio in the european biopharmaceutical industry
Valérie Sabatier
,
Vincent Mangematin
,
Tristan Rouselle
Journal articles
hal-00430782v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Start-up mid and long term strategic management using a business model portfolio
Valérie Sabatier
,
Tristan Rouselle
,
Vincent Mangematin
Valérie Chanal. Rethinking Business Models for innovation Lessons from entrepreneurial projects, 2011
Book sections
hal-01107569v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Rethinking business models for innovation
Valérie Chanal
,
Sigmund Akselsen
,
Sylvie Blanco
,
Marie-Laurence Caron-Fasan
,
Bernard Cartoux
,
et al.
Rethinking Business Models for innovation, pp.154, 2011
Book sections
halshs-00566298v2
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
When technological discontinuities and disruptive business models challenge dominant industry logics: insights from the drugs industry
Valérie Sabatier
,
Adrienne Kennard
,
Vincent Mangematin
Journal articles
hal-00658727v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Becoming Through Doing: How Experimental Spaces Enable Organizational Identity Work
Neva Bojovic
,
Valérie Sabatier
,
Emmanuel Coblence
Journal articles
halshs-02376220v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Orchestrating networks in the biopharmaceutical industry: small hub firms can do it
Valérie Sabatier
,
Vincent Mangematin
,
Tristan Rouselle
Journal articles
hal-00468340v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|